The information currently found on this site is for the 2016 Lung Conference,
"Lung Immune Responses and Inflammation in Health and Disease."

Information for the 2018 Lung Conference is forthcoming.
SAVE THE DATE: October 4-5, 2018


The Pittsburgh-Munich International Lung Conference is an educational conference held annually to increase awareness of the medical and scientific advances being made in treating lung disease.

The 2016 Pittsburgh-Munich Lung conference will be hosted by the Division of Pulmonary and Critical Care Medicine at the University of Pittsburgh, a leader in Pulmonary Medicine, in alliance with the Comprehensive Pneumology Center (CPC), a translational research center of excellence combining three strong scientific partners: the Ludwig-Maximilians-University Munich, Germany with its university hospital, the Helmholtz Zentrum München and the Asklepios Clinics München-Gauting. The theme of this year’s Pittsburgh-Munich Lung Conference is immune responses in the lung in health and disease highlighting the important role the immune system plays in preserving lung health despite constant provocation by environmental insults and its inappropriate engagement during disease.

The Conference will showcase cutting-edge basic and translational research to understand defense against respiratory pathogens with utilization of immunological tools to develop a universal vaccine for flu. It will also bring into focus immune mechanisms that incite and perpetuate different lung diseases. Innovative treatment strategies targeting the immune system to improve patient outcomes in lung diseases will be an important focus of this conference. A new subtopic that will be included in 2016 is technological advancements that can be harnessed to study and treat lung diseases. 

Elucidating the immune basis of viral and bacterial pneumonia, multi-drug resistant lower respiratory tract infections, cystic fibrosis, asthma, sarcoidosis, chronic obstructive pulmonary disease (COPD), acute lung injury (ALI), and lung allograft rejection are essential for the development of novel diagnostics and therapeutics targeting lung diseases.  The conference will bring together established scientists from multiple disciplines and institutions who are contributing in a major way to unraveling the immune system to improve lung health and will also allow junior investigators and trainees to learn and contribute in order to ensure the future vitality of the field.

Sessions will cover the following topics:

  1. Immune Response and Inflammation in Defense against Respiratory Pathogens
  2. Immune Response and Inflammation in Promotion of Lung Diseases
  3. Cutting-edge Technologies to Probe Immune Cells and Relevance in Lung Disease
  4. Targeting the Immune System to Treat Lung Diseases

Each session will be end with a panel discussion with an opportunity for questions for further interaction among participants. 

We look forward to your participation in the conference.

Course Directors:
Anuradha Ray, PhD
Janet S. Lee, MD